Related Experiment Videos

Clinical and hemodynamic effects of stepwise lowering of hemoglobin concentration in patients with intermittent

F Celsing1, M Eriksson, U Markström

  • 1Department of Medicine, Karolinska Institute, Danderyd Hospital, Stockholm.

Angiology
|January 1, 1994
PubMed

Insights

Lowering hemoglobin (Hb) levels through venesection did not improve walking distance or hemodynamics in patients with intermittent claudication. This study found no clinical benefit from reducing Hb concentration in this patient group.

Area of Science:

  • Vascular Medicine
  • Hematology

Background:

  • Intermittent claudication (IC) significantly impacts quality of life.
  • Hemoglobin (Hb) concentration is a key factor in oxygen transport.

Purpose of the Study:

  • To evaluate the effect of stepwise hemoglobin reduction on maximal walking distance (MWD) and hemodynamics in patients with severe intermittent claudication.
  • To determine if hemodilution via venesection offers clinical benefits for IC patients.

Main Methods:

  • A study group (n=6) underwent repeated venesections to lower Hb levels.
  • A control group (n=6) did not undergo venesections.
  • Measurements included MWD, transcutaneous oxygen pressure, heart rate, pain-free walking distance, ankle pressure, and blood lactate.

Main Results:

  • Reducing Hb concentration from 151 +/- 4 to 121 +/- 3 g/L did not significantly alter MWD (282 +/- 62m vs. 255 +/- 54m).
  • Transcutaneous oxygen pressure, maximal heart rate, pain-free walking distance, ankle pressure, and blood lactate remained unchanged.
  • Venesection of ~1.4L whole blood over 14 days did not alter blood volume.

Conclusions:

  • Hemodilution achieved through venesection does not provide clinically or physiologically beneficial effects for patients with severe intermittent claudication.
  • Significant reductions in arterial oxygen content within the normal Hb range did not impact hemodynamics or clinical symptoms in IC patients.

Related Concept Videos